Clinical Trials Directory

Trials / Conditions / Schnitzler Syndrome

Schnitzler Syndrome

8 registered clinical trials studyying Schnitzler Syndrome — 1 currently recruiting.

StatusTrialSponsorPhase
WithdrawnStudy of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
NCT04213274
R-Pharm Overseas, Inc.Phase 2
RecruitingAutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715
University of Siena—
TerminatedPilot Study of Dapansutrile Capsules in Schnitzler's Syndrome
NCT03595371
Olatec Therapeutics LLCPhase 2
CompletedIlaris® Effects in Schnitzler Syndrome (ILESCH)
NCT01390350
Charite University, Berlin, GermanyPhase 2
CompletedIlaris (Canakinumab) in the Schnitzler Syndrome
NCT01245127
Universitaire Ziekenhuizen KU LeuvenPhase 2
CompletedEfficacy and Safety of Canakinumab in Schnitzler Syndrome
NCT01276522
Radboud University Medical CenterPhase 2
CompletedSchnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors
NCT00933296
University Hospital, Strasbourg, France—
CompletedSafety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
NCT01045772
Charite University, Berlin, GermanyPhase 2